CME Group
Suresh Veluru is a seasoned IT Business Analyst with extensive experience in risk and pricing systems, currently serving as Lead IT Business Analyst at CME Group since August 2013, focusing on the Risk Engine Project for interest rate swaps margining using Calypso and OpenGamma. Previously, Suresh held the position of Team Lead at Accenture Technology Solutions from February 2010 to August 2013, working primarily with Bank of America's OTC Derivatives Back Office Processing, and leading various projects related to derivatives and trading systems. Earlier roles included Assistant Systems Analyst at Tata Consultancy Services, contributing to business analysis and test management for multiple financial institutions, and Management Trainee at Standard Chartered Asset Management Co. Suresh holds an MBA in Financial Management from the Indian Institute of Information Technology & Management and a Bachelor of Technology in Electrical and Electronics Engineering from Jawaharlal Nehru Technological University.
This person is not in any teams
This person is not in any offices
CME Group
26 followers
As the world's leading and most diverse derivatives marketplace, CME Group is where the world comes to manage risk. CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. CME Group brings buyers and sellers together through its CME Globex® electronic trading platform and its trading facilities in New York and Chicago. CME Group also operates CME Clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through CME ClearPort®. These products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.